77. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freitag, 29. April 2011 (Posterbereich K) 10:00-11:30

Postervorträge

Myokarderkrankungen / Karditis

Diskussionsleiter: H. Baumgartner (Münster), E. Erdmann (Köln)

(P1016) Proarrhythmic Effect of Steroid Therapy in Cardiac Sarcoidosis

D. Dechering, A. Bittner, J. Köbe, K. Wasmer, S. Kochhäuser, S. Zellerhoff, G. Mönnig, L. Eckardt (Münster)
(P1017) Herzinsuffizienz bei Noncompaction Kardiomyopathie: Daten des Deutschen-Noncompaction-Registers (ALKK)

B. J. Gerecke, C. Stöllberger, W. Fehske, B. Schneider, D. Nothnagel, R. Engberding (Wolfsburg, Köln, Lübeck, Ludwigsburg; Wien, AT)
(P1018) Untersuchungen zur kardioprotektiven Wirkung von Endothelinantagonisten unter Doxorubicingabe.

M. Schwebe, S. Bien, S. Schlensak, A. Poesch, H. K. Kroemer (Greifswald)
(P1019) Comprehensive Assessment of Long Term Enzyme Replacement Therapy on Fabry Disease – The 5 Year Data

K. Baumgärtner, M. Niemann, A. Emmert, F. Breunig, J. Strotmann, M. Beer, C. Sommer, G. Ertl, C. Wanner, F. Weidemann (Würzburg, Kiel)
(P1020) Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) using Polyvinyl Alcohol Foam particles in the treatment of Hypertrophic Obstructive Cardiomyopathy: A single center experience

M. Roser, A. Sander, E. Wellnhofer, S. Dreysse, E. Fleck (Berlin)
(P1021) Molecular effects of the amino acid exchanges R20C and K206Q of cardiac Troponin I, linked to familial hypertrophic cardiomyopathy (FHC)

M. Saes, D. Kindsvater, I. Morano, A. Mügge, K. Jaquet (Bochum, Berlin)
(P1022) Doxorubicin induced Cardiomyopathy: Influence of oxysteroles and the cholesterol transporters ABCA1 and ABCG1

M. Grube, T. Budde, H. E. Meyer zu Schwabedissen, M. Schwebe, S. Bien, D. Lütjohann, H. K. Kroemer (Greifswald, Bonn)
(P1023) Effects of enzyme replacement therapy with agalsidase in patients with Fabry’s disease on cardiac mass and function: an analysis of the Fabry-Münster-Study (FaMüS) data

M. A. Engelen, T. B. Baumeister, E. von dem Bussche, J. Rosmus, F. Landeta, K. Tiemann, T. Marquardt, T. Duning, N. Osada, E. Brand, R. M. Schäfer, J. Stypmann (Münster)
(P1024) Different application protocols of cardioprotective cyclic peptides yield similar therapeutic efficacies in beta1-receptor antibody-induced cardiomyopathy.

V. Boivin, A. Schlipp, C. Zechmeister, N. Deubner, D. Berliner, G. Ertl, M. Lohse, R. Jahns (Würzburg)
(P1025) Fully functional membrane beta1-adrenoceptors with single amino-acid mutations in the second extracellular loop are not recognized by conformational anti-beta1-receptor antibodies.

M. Sättele, A. Schlipp, J. Ullrich, M. Lohse, R. Jahns, V. Boivin (Würzburg)
(P1026) Cardiac OCTN2: Expression in dilated cardiomyopathy and impact on cardiac function

K. Bonitz, M. Schwebe, S. Heinrich, S. Ameling, G. Jedlitschky, U. Völker, S. B. Felix, M. Grube, H. K. Kroemer (Greifswald)
(P1027) Eosinophilic myocarditis mimicking a midventricular Tako-Tsubo cardiomyopathy

H. Jansen, K. Mortensen, P. Linsel-Nitschke, W. Lieb, H. Schunkert, M. Reppel (Lübeck)
(P1028) Impact of pericardectomy on long- and short-term outcome in patients with chronic constrictive pericaritis

C. Mattusch, U. M. Müller, A. Linke, G. C. Schuler (Leipzig)
(P1029) Pathogenetic role and diagnostic value of vascular endothelial growth factor in malignant pericardial effusion

K. Karatolios, S. Pankuweit, A. Richter, R. Moosdorf, B. Maisch (Marburg)